Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.15M Buy
14,742
+2,970
+25% +$245K 0.06% 105
2022
Q1
$1M Buy
11,772
+2,354
+25% +$226K 0.04% 107
2021
Q4
$1.13M Buy
9,418
+1,672
+22% +$208K 0.05% 105
2021
Q3
$958K Buy
7,746
+1,206
+18% +$155K 0.04% 143
2021
Q2
$785K Buy
6,540
+2,902
+80% +$331K 0.04% 166
2021
Q1
$383K Buy
3,638
+1,391
+62% +$141K 0.02% 209
2020
Q4
$229K Buy
2,247
+500
+29% +$47K 0.01% 263
2020
Q3
$147K Buy
1,747
+70
+4% +$5.45K 0.01% 296
2020
Q2
$109K Hold
1,677
0.01% 315
2020
Q1
$109K Buy
1,677
+1,386
+476% +$109K 0.01% 286
2019
Q4
$22.9K Buy
291
+91
+46% +$7.08K ﹤0.01% 621
2019
Q3
$15.9K Hold
200
﹤0.01% 682
2019
Q2
$16.7K Buy
+200
New +$15.9K ﹤0.01% 687
2018
Q4
Sell
-200
Closed -$16K 1153
2018
Q3
$16K Hold
200
﹤0.01% 739
2018
Q2
$13.5K Hold
200
﹤0.01% 779
2018
Q1
$15.4K Hold
200
﹤0.01% 727
2017
Q4
$13.6K Hold
200
﹤0.01% 772
2017
Q3
$12.5K Buy
+200
New +$12K ﹤0.01% 786

Other funds holding XYL

RBC Europe's XYL Position: Q2 2022 in Review

RBC Europe increased its Xylem (XYL) stake by 25% in Q2 2022, buying an estimated $245K and bringing the position to 14,742 shares worth $1.15M. The position accounts for 0.06% of the portfolio, ranked #105.

RBC Europe first reported a position in XYL in Q3 2017 and has held it in 18 quarters since. 725 funds tracked by Wall St. Rank hold XYL as of Q2 2022.

  • RBC Europe held 14,742 shares of Xylem worth $1.15M as of Q2 2022.
  • RBC Europe bought 2,970 Xylem shares in Q2 2022, an estimated $245K.
  • Xylem made up 0.06% of RBC Europe's portfolio in Q2 2022, its #105 holding.
  • RBC Europe first reported a position in Xylem in Q3 2017 and has held it in 18 quarters since.
  • 725 funds tracked by Wall St. Rank held Xylem as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.